ALBANY, New York--(BUSINESS WIRE)--A new research study based on the global transfection technology market published by Transparency Market Research states that the market will grow at a CAGR of 9.7% between 2013 and 2019. The global transfection technology market had a net worth of nearly US$386.4 million in 2012 and will increase to US$768.2 million by 2019.

Browse Report: http://www.transparencymarketresearch.com/transfection-technology.html

The report is titled as “Transfection Technology Market (Reagent-based method, Instrument-based method and Virus-based method) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019.”

The report states that rising prevalence of a number of cancers such as breast cancer, lung cancer and prostate cancer, and obesity amongst the global population are the chief factors driving the global transfection technology market. Apart from this, a number of cardiovascular diseases such as ischemic heart disease and arrhythmias, and the expanding industry of mass protein production are some of the factors further accentuating the global transfection technology market.

Request sample report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1001

The report focuses on three major segments of the global transfection technology market: transfection technology methods, applications, and prominent regional markets.

The segment transfection-technology-methods is further segmented into virus-based, instrument-based, and reagent-based methods. The report further classifies reagent-based transfection technology segment into cationic polymers, activated dendrimers, DEAE-dextran, lipid mediated transfection (Lipofection), magnetic beads, and calcium phosphate.

All Medical Devices Reports: http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

Reagent-based transfection technology market has observed significant rise in demands owing to the technology’s cost-effectiveness and simpler functionality during transfection. North American regional transfection technology market contributed to largest revenue shares, nearly 45% in 2012. Rising awareness about transfection applications and government initiatives will promote these technologies in future.

Browse All Press Releases: http://www.transparencymarketresearch.com/press-releases.htm

Other Reports

About Us:

TMR is a U.S. based market intelligence company driven by a global team of high-pedigree industry consultants, analysts, and researchers. TMR leverages its worldwide Syndicated Research, Custom Research, and Market Consulting expertise to help businesses make accurate decisions.

The company’s multi-disciplinary expertise has made it the preferred growth partner of hundreds of companies worldwide, from multibillion dollar conglomerates to emerging regional businesses. TMR’s exclusive blend of quantitative forecasting and trends analysis draws on proprietary data sources, tools, and techniques.